Medicine & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Axonyx, Inc.
Axonyx reports loss of $0.07 per share
June 2nd, 2006
Axonyx, Inc., (AXYX) announced results for the first quarter-ended March 31, 2006. The company reported a net loss of $4,017,000 or $0.07 per share for the first quarter of 2006 compared to a net loss of $10,433,000 or $0.19 per share for the first quarter of 2005. The company had no revenue for the quarter ended March 31, 2006 as compared to $403,000 in the first quarter of 2005. Research and development costs for the first quarter 2006 were $2,661,000 compared to $9,322,000 for the same period in 2005. The reduction reflects a decline in Phenserine program expenditures of $7,046,000 due to the completion/curtailment of the Phenserine trials in late...
Source: Medicine & Law Weekly (2006-06-02)
|
